112733-06-9 | 1(2H)-Quinazolineaceticacid, 3-[(4-bromo-2-fluorophenyl)methyl]-7-chloro-3,4-dihydro-2,4-dioxo-

Packsize	Purity	Availability	Price	Discounted Price
5mg	99%	1 week	$440.00	$308.00
10mg	99%	1 week	$696.00	$487.00
25mg	99%	1 week	$1,340.00	$938.00
50mg	99%	1 week	$2,120.00	$1,484.00
100mg	99%	1 week	$3,350.00	$2,345.00

Description

• Catalog Number: AD75475
• Chemical Name: 1(2H)-Quinazolineaceticacid, 3-[(4-bromo-2-fluorophenyl)methyl]-7-chloro-3,4-dihydro-2,4-dioxo-
• CAS Number: 112733-06-9
• Molecular Formula: C17H11BrClFN2O4
• Molecular Weight: 441.6356
• MDL Number: MFCD00865809
• SMILES: Brc1ccc(c(c1)F)Cn1c(=O)c2ccc(cc2n(c1=O)CC(=O)O)Cl

Upstream Synthesis Route

Zenarestat is a potent and selective aldose reductase inhibitor that holds great significance in chemical synthesis. This compound, commonly used in pharmaceutical research, plays a crucial role in the development of various medicines targeting diabetic complications. By inhibiting aldose reductase, Zenarestat helps prevent the accumulation of harmful glucose metabolites, making it a valuable tool in the synthesis of anti-diabetic drugs. Additionally, its ability to modulate the polyol pathway highlights its importance in the creation of novel therapeutic agents for various conditions. In the realm of chemistry, Zenarestat serves as a key player in the synthesis of compounds aimed at combating diabetes and related disorders.